A long-acting cholinesterase inhibitor reverses spatial memory deficits in mice
- 1 September 1988
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 31 (1), 141-147
- https://doi.org/10.1016/0091-3057(88)90325-5
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of MeynertPsychopharmacology, 1987
- Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementiaEuropean Journal of Biochemistry, 1986
- Selective memory loss following nucleus basalis lesions: Long term behavioral recovery despite persistent cholinergic deficienciesPharmacology Biochemistry and Behavior, 1985
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: A review and some new resultsNeuroscience & Biobehavioral Reviews, 1982
- Physostigmine and Recent Memory: Effects in Young and Aged Nonhuman PrimatesScience, 1979
- Reversal of central anticholinergic syndrome by galanthamineJAMA, 1977
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEThe Lancet, 1976
- Short-term memory in the rhesus monkey: Disruption from the anti-cholinergic scopolaminePharmacology Biochemistry and Behavior, 1976
- Galanthamine hydrobromide versus neostigmineAnaesthesia, 1974